Shares of Smith & Nephew plc (LON:SN – Get Free Report) have earned a consensus rating of “Hold” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is GBX 1,382.62.
A number of equities analysts have issued reports on SN shares. UBS Group reissued a “neutral” rating and issued a GBX 1,300 target price on shares of Smith & Nephew in a report on Tuesday, May 5th. Berenberg Bank reiterated a “hold” rating and set a GBX 13 price target on shares of Smith & Nephew in a research report on Friday, May 1st. Jefferies Financial Group reiterated a “buy” rating and set a GBX 2,760 price target on shares of Smith & Nephew in a research report on Thursday, May 21st. Royal Bank Of Canada reissued a “sector perform” rating and issued a GBX 1,350 price target on shares of Smith & Nephew in a report on Monday, June 29th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a GBX 1,400 price objective on shares of Smith & Nephew in a research report on Thursday, June 11th.
View Our Latest Analysis on Smith & Nephew
Smith & Nephew Price Performance
Smith & Nephew Company Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Featured Articles
- Five stocks we like better than Smith & Nephew
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.
